Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma.

Lee JH, Rangappa S, Mohan CD; Basappa, Sethi G, Lin ZX, Rangappa KS, Ahn KS.

Biomolecules. 2019 Sep 30;9(10). pii: E550. doi: 10.3390/biom9100550.

2.

Triazole-Pyridine Dicarbonitrile Targets Phosphodiesterase 4 to Induce Cytotoxicity in Lung Carcinoma Cells.

Keerthy HK, Mohan S, Basappa, Bharathkumar H, Rangappa S, Svensson F, Bender A, Mohan CD, Rangappa KS, Bhatnagar R.

Chem Biodivers. 2019 Sep;16(9):e1900234. doi: 10.1002/cbdv.201900234. Epub 2019 Aug 29.

PMID:
31287204
3.

Biofabrication of Zinc Oxide Nanoparticles With Syzygium aromaticum Flower Buds Extract and Finding Its Novel Application in Controlling the Growth and Mycotoxins of Fusarium graminearum.

Lakshmeesha TR, Kalagatur NK, Mudili V, Mohan CD, Rangappa S, Prasad BD, Ashwini BS, Hashem A, Alqarawi AA, Malik JA, Abd Allah EF, Gupta VK, Siddaiah CN, Niranjana SR.

Front Microbiol. 2019 Jun 12;10:1244. doi: 10.3389/fmicb.2019.01244. eCollection 2019.

4.

Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds.

Mohan CD, Hari S, Preetham HD, Rangappa S, Barash U, Ilan N, Nayak SC, Gupta VK, Basappa, Vlodavsky I, Rangappa KS.

iScience. 2019 May 31;15:360-390. doi: 10.1016/j.isci.2019.04.034. Epub 2019 May 3. Review.

5.

Synthesis of CC, CN coupled novel substituted dibutyl benzothiazepinone derivatives and evaluation of their thrombin inhibitory activity.

Baburajeev CP, Mohan CD, Pandey V, Rangappa S, Shivalingegowda N, Kalash L, Devaraja S, Bender A, Lobie PE, Rangappa KS, Basappa.

Bioorg Chem. 2019 Jun;87:142-154. doi: 10.1016/j.bioorg.2019.03.004. Epub 2019 Mar 5.

PMID:
30884308
6.

Sulfated Ceria Catalyzed Synthesis of Imidazopyridines and Their Implementation as DNA Minor Groove Binders.

Mohan S, Rangappa S, Anilkumar NC, Fuchs JE, Bender A, Basappa, Rangappa KS, Bhatnagar R.

Chem Biodivers. 2019 May;16(5):e1800435. doi: 10.1002/cbdv.201800435. Epub 2019 Apr 10.

PMID:
30702795
7.

Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.

Gebrehiwot AG, Melka DS, Kassaye YM, Rehan IF, Rangappa S, Hinou H, Kamiyama T, Nishimura SI.

PLoS One. 2018 Dec 28;13(12):e0209515. doi: 10.1371/journal.pone.0209515. eCollection 2018.

8.

N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway.

Mohan CD, Bharathkumar H, Dukanya, Rangappa S, Shanmugam MK, Chinnathambi A, Alharbi SA, Alahmadi TA, Bhattacharjee A, Lobie PE, Deivasigamani A, Hui KM, Sethi G, Basappa, Rangappa KS, Kumar AP.

Front Pharmacol. 2018 Nov 5;9:1125. doi: 10.3389/fphar.2018.01125. eCollection 2018.

9.

Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.

Totiger TM, Srinivasan S, Jala VR, Lamichhane P, Dosch AR, Gaidarski AA 3rd, Joshi C, Rangappa S, Castellanos J, Vemula PK, Chen X, Kwon D, Kashikar N, VanSaun M, Merchant NB, Nagathihalli NS.

Mol Cancer Ther. 2019 Feb;18(2):301-311. doi: 10.1158/1535-7163.MCT-18-0464. Epub 2018 Nov 7.

PMID:
30404927
10.

Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation.

Pandey V, Wang B, Mohan CD, Raquib AR, Rangappa S, Srinivasa V, Fuchs JE, Girish KS, Zhu T, Bender A, Ma L, Yin Z, Basappa, Rangappa KS, Lobie PE.

Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10505-E10514. doi: 10.1073/pnas.1804897115. Epub 2018 Oct 11.

11.

Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cells.

Gilandoust M, Harsha KB, Mohan CD, Raquib AR, Rangappa S, Pandey V, Lobie PE, Basappa, Rangappa KS.

Bioorg Med Chem Lett. 2018 Jul 15;28(13):2314-2319. doi: 10.1016/j.bmcl.2018.05.020. Epub 2018 May 9.

PMID:
29789259
12.

A trisubstituted pyrazole derivative reduces DMBA-induced mammary tumor growth in rats by inhibiting estrogen receptor-α expression.

Ananda H, Sharath Kumar KS, Sudhanva MS, Rangappa S, Rangappa KS.

Mol Cell Biochem. 2018 Dec;449(1-2):137-144. doi: 10.1007/s11010-018-3350-8. Epub 2018 May 18.

PMID:
29777335
13.

Endophytic Fungi-Alternative Sources of Cytotoxic Compounds: A Review.

Uzma F, Mohan CD, Hashem A, Konappa NM, Rangappa S, Kamath PV, Singh BP, Mudili V, Gupta VK, Siddaiah CN, Chowdappa S, Alqarawi AA, Abd Allah EF.

Front Pharmacol. 2018 Apr 26;9:309. doi: 10.3389/fphar.2018.00309. eCollection 2018. Review.

14.

Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells.

Mohan CD, Anilkumar NC, Rangappa S, Shanmugam MK, Mishra S, Chinnathambi A, Alharbi SA, Bhattacharjee A, Sethi G, Kumar AP, Basappa, Rangappa KS.

Front Oncol. 2018 Mar 19;8:42. doi: 10.3389/fonc.2018.00042. eCollection 2018.

15.

Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.

Nirvanappa AC, Mohan CD, Rangappa S, Ananda H, Sukhorukov AY, Shanmugam MK, Sundaram MS, Nayaka SC, Girish KS, Chinnathambi A, Zayed ME, Alharbi SA, Sethi G, Basappa, Rangappa KS.

PLoS One. 2017 Apr 6;12(4):e0175659. doi: 10.1371/journal.pone.0175659. eCollection 2017.

16.

Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.

Baburajeev CP, Mohan CD, Rangappa S, Mason DJ, Fuchs JE, Bender A, Barash U, Vlodavsky I, Basappa, Rangappa KS.

BMC Cancer. 2017 Mar 31;17(1):235. doi: 10.1186/s12885-017-3214-8.

17.

Elicitation of resistance and associated defense responses in Trichoderma hamatum induced protection against pearl millet downy mildew pathogen.

Siddaiah CN, Satyanarayana NR, Mudili V, Kumar Gupta V, Gurunathan S, Rangappa S, Huntrike SS, Srivastava RK.

Sci Rep. 2017 Mar 21;7:43991. doi: 10.1038/srep43991.

18.

Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer.

Sebastian A, Pandey V, Mohan CD, Chia YT, Rangappa S, Mathai J, Baburajeev CP, Paricharak S, Mervin LH, Bulusu KC, Fuchs JE, Bender A, Yamada S, Basappa, Lobie PE, Rangappa KS.

ACS Omega. 2016 Dec 31;1(6):1412-1424. doi: 10.1021/acsomega.6b00251. Epub 2016 Dec 28.

19.

Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.

Nirvanappa AC, Mohan CD, Rangappa S, Ananda H, Sukhorukov AY, Shanmugam MK, Sundaram MS, Nayaka SC, Girish KS, Chinnathambi A, Zayed ME, Alharbi SA, Sethi G, Basappa, Rangappa KS.

PLoS One. 2016 Sep 29;11(9):e0163209. doi: 10.1371/journal.pone.0163209. eCollection 2016. Erratum in: PLoS One. 2017 Apr 6;12 (4):e0175659.

20.

An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway.

Sulaiman NB, Mohan CD, Basappa S, Pandey V, Rangappa S, Bharathkumar H, Kumar AP, Lobie PE, Rangappa KS.

Int J Oncol. 2016 Sep;49(3):1221-9. doi: 10.3892/ijo.2016.3615. Epub 2016 Jul 6.

PMID:
27500741

Supplemental Content

Loading ...
Support Center